Related Experiment Video
Updated: Jul 14, 2026
05:03
Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Porphyrin-retinamides: synthesis and cellular studies
Martha Sibrian-Vazquez1, Timothy J Jensen, M Graça H Vicente
1Department of Chemistry, Louisiana State University, Baton Rouge, Louisiana 70803, USA.
Bioconjugate Chemistry
|May 24, 2007
Summary
New porphyrin-retinamide conjugates were synthesized and tested for biological properties. PEG-containing conjugates, especially porphyrin-PEG-13-cis-retinamide, showed enhanced cellular uptake and localization in lysosomes and ER, with low toxicity.
Area of Science:
- Medicinal Chemistry
- Photodynamic Therapy
- Drug Delivery Systems
Background:
- Retinoids are crucial for cell differentiation and vision.
- Porphyrins are photosensitizers with applications in cancer therapy.
- Conjugating retinoids with porphyrins may offer targeted therapeutic strategies.
Purpose of the Study:
- To synthesize novel porphyrin-retinamide conjugates.
- To evaluate the cellular uptake, localization, and toxicity of these conjugates.
- To investigate the impact of PEGylation and linker type on biological properties.
Main Methods:
- Synthesis of four porphyrin-retinamide conjugates with varying retinoid isomers and linker strategies (direct vs. PEG spacer).
- In vitro evaluation of cellular uptake and localization in HEp2 and SK-N-DZ cell lines.
- Assessment of cytotoxicity in both dark and photodynamic conditions.
Main Results:
- Porphyrin-retinamides were successfully synthesized and characterized.
- Cellular uptake varied, with PEGylated conjugates showing maximal accumulation, particularly porphyrin-PEG-13-cis-retinamide.
- Conjugates localized in cellular vesicles (lysosomes) and ER (PEGylated ones), with low toxicity in HEp2 cells and moderate toxicity in SK-N-DZ cells.
Conclusions:
- PEGylation enhances cellular accumulation and alters intracellular localization of porphyrin-retinamides.
- Porphyrin-PEG-13-cis-retinamide demonstrates promising properties for potential therapeutic applications.
- The study provides insights into the structure-activity relationships of porphyrin-retinamide conjugates.
